Hopped on HLB파나진

I bought HLB파나진 today. Saw the whole group move and reacted right away.

Body moved first on the FDA news

HLB group bile duct cancer drug approval sent related names flying. The 75 composite score means this momentum is still alive. So I didn't let it pass and took some.

Holdings stayed put. No extra moves, so the portfolio now just has this fresh HLB파나진 added. The rest stays under watch.